Repurposing a drug to punish carbapenem-resistant Acinetobacter baumannii
Proceedings of the National Academy of Sciences · 17.06.2025 · 122 (24)
DOI: 10.1073/pnas.2423650122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 10.06.2025. Verfasst von Jennifer M Colquhoun und 10 weiteren Autor:innen. Beteiligte Einrichtung: Research Service, Atlanta VA Medical Center, Decatur, GA 30033. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Drug Repositioning, Carbapenems, Anti-Bacterial Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: U.S. Department of Veterans Affairs (VA), BLRD VA, NIDDK NIH HHS.
Abstract (Originalsprache)
The OXA β-lactamases in Acinetobacter baumannii represent a primary mechanism for resistance to the carbapenems, a class of antibiotics that represent a last line for treatment. In a screen of an U.S. Food and Drug Administration (FDA)-approved drug library, we identified fendiline, a calcium channel blocker, had significantly more antimicrobial activity against OXA-23 expressing cells. Genetic and proteomic studies revealed that fendiline inhibited the essential lipoprotein trafficking pathway (Lol) in both A. baumannii (LolFD) and Escherichia coli (LolCDE). We demonstrate that OXA-23 is an outer membrane lipoprotein and its overexpression resulted in increased lethality in lolFD- depleted A. baumannii . Our results indicate that overexpression of the OXA-23 β-lactamase in A. baumannii stresses normal lipoprotein trafficking, which makes these cells more susceptible to fendiline. Overall, our data reveal a link between carbapenem resistance and the Lol pathway, which can be leveraged for new drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Service, Atlanta VA Medical Center, Decatur, GA 30033.
- Department of Chemistry, Emory University, Atlanta, GA 30322.
- Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322.
- Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA 30322.
- Emory Antibiotic Resistance Center, Emory University School of Medicine, Atlanta, GA 30322.
- Department of Bioscience, Center for Functional Protein Assemblies, Technical University of Munich, School of Natural Sciences, Garching D-85747, Germany.
ORCID-Profile: Andrew Ji, Julianna Marotta, Franziska A V Elsen, Kerrie L May, Marcin Grabowicz, William M Wuest, Philip N Rather
Förderung
- U.S. Department of Veterans Affairs (VA)
- BLRD VA
- NIDDK NIH HHS
- NIGMS NIH HHS
- NIAID NIH HHS
- HHS | NIH (NIH)
Zitieren
APA
Colquhoun, J. M., Brzezinski, C. U., Ji, A., Marotta, J., Elsen, F. A. V., Bonomo, R. A., May, K. L., Sieber, S. A., Grabowicz, M., Wuest, W. M., & Rather, P. N. (2025). Repurposing a drug to punish carbapenem-resistant Acinetobacter baumannii. Proceedings of the National Academy of Sciences, 122(24). https://doi.org/10.1073/pnas.2423650122
Vancouver
Colquhoun JM, Brzezinski CU, Ji A, Marotta J, Elsen FAV, Bonomo RA, et al. Repurposing a drug to punish carbapenem-resistant Acinetobacter baumannii. Proceedings of the National Academy of Sciences. 2025;122(24). doi:10.1073/pnas.2423650122
BibTeX
@article{Colquhoun2025,
author = {Colquhoun, Jennifer M and Brzezinski, Carter U and Ji, Andrew and Marotta, Julianna and Elsen, Franziska A V and Bonomo, Robert A and May, Kerrie L and Sieber, Stephan A and Grabowicz, Marcin and Wuest, William M and Rather, Philip N},
title = {Repurposing a drug to punish carbapenem-resistant Acinetobacter baumannii},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
volume = {122},
number = {24},
doi = {10.1073/pnas.2423650122}
}
EUVIMED